None

Marinomed granted Chinese patent for anti-viral polymer

Austrian company Marinomed Biotechnologie GmbH, which is focused on the development of innovative therapies for respiratory diseases, has been granted a patent entitled ‘Antiviral polymer’ by the...

Marinomed Appoints Head of Development - Presenting during seminar on influenza at BIO-Europe in Düsseldorf

Vienna, Austria, 27 October 2011- Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has appointed Dr. A...

Marinomed Granted Chinese Patent for Antiviral Polymer

Vienna, Austria – 19 November 2012 – Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, today announced that it has been gran...

Marinomed's MAM-06.301 Achieves Preclinical POC - Study published in BMC Immunology (CollegeHill)

Vienna, Austria, 25 May, 2010 - Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that MAM-06.301 has achieved...

Marinomed’s Antiviral Effective in Clinical Trial for Common Cold

Study published in Respiratory Research Vienna, Austria, 11 August 2010 - Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, a...

Marinomed wins STEP award in "Market-Customer" category and special award for strategic partnerships

Vienna, Austria, 19 November 2010 - Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, today announced that it has won the &euro...

Marinomed's Iota-Carrageenan Nasal Spray Achieves Positive Clinical Results Against Common Cold

Results Presented in an Oral Presentation at ISRVI in Istanbul, March 23-26th Vienna, Austria- 21 March 2012 - Marinomed Biotechnologie GmbH, a company focused on the development of innovative...

Marinomeds Iota-Carrageenan Effective Against H1N1 - Study published in PLoS ONE

Vienna, Austria, 15th December 2010 - Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, today announced that in vitro and in-vi...

DNA methylation, a key player in pluripotency.

Muscle wasting (sarcopenia/cachexia) and malnutrition.

Contents: biotechnologie journal 4/2012.

Regulatory and Metabolic Networks for Amino Acid Production by Corynebacterium glutamicum.

Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.

E6 viral oncoproteins are key players in epithelial tumors induced by papillomaviruses in vertebrates, including cervical cancer in humans. E6 proteins target many host proteins by specifically intera...